CCK Receptor Antagonists
- 1 October 1998
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 31 (4) , 519-524
- https://doi.org/10.1016/s0306-3623(98)00078-0
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Synthesis and Stereochemical Structure−Activity Relationships of 1,3-Dioxoperhydropyrido[1,2-c]pyrimidine Derivatives: Potent and Selective Cholecystokinin-A Receptor AntagonistsJournal of Medicinal Chemistry, 1997
- Pharmacological evaluation of IQM‐95,333, a highly selective CCKAreceptor antagonist with anxiolytic‐like activity in animal modelsBritish Journal of Pharmacology, 1997
- A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety DisorderJournal of Clinical Psychopharmacology, 1995
- Cholecystokinin in psychiatric research: A time for cautious excitementJournal of Psychiatric Research, 1995
- A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorderBiological Psychiatry, 1995
- Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte Cell lineEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cellsPeptides, 1992
- Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivativesJournal of Medicinal Chemistry, 1992
- Interaction of CCK with pancreatic acinar cellsTrends in Pharmacological Sciences, 1989
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985